Cleared Traditional

K260226 - ElintMAX Respiratory Monitor (ElintMAX Monitor A1)

K260226 is an FDA 510(k) clearance for ElintMAX Respiratory Monitor (ElintMAX ..., manufactured by Amptron Medical, Inc.. The device is a Class 2 Anesthesiology device with product code BZK cleared through the Traditional 510(k) pathway after a 233-day FDA review.

K260226 · Amptron Medical, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2026
Decision
233d
Days
Class 2
Risk

K260226 is an FDA 510(k) clearance for the ElintMAX Respiratory Monitor (ElintMAX Monitor A1). Classified as Spirometer, Monitoring (w/wo Alarm) (product code BZK), Class II - Special Controls.

Submitted by Amptron Medical, Inc. (Carlsbad, US). The FDA issued a Cleared decision on September 16, 2026 after a review of 233 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1850 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Amptron Medical, Inc. devices

FDA 510(k) Submission Details - K260226

510(k) Number K260226 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 26, 2026
Decision Date September 16, 2026
Days to Decision 233 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d slower than avg
Panel avg: 140d · This submission: 233d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BZK Device Classification - Class 2, Special Controls

Product Code BZK Spirometer, Monitoring (w/wo Alarm)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZK Spirometer, Monitoring (w/wo Alarm)

All 38
Devices cleared under the same product code (BZK) and FDA review panel - the closest regulatory comparables to K260226.
BEACON Caresystem Model 00002144
K192584 · Mermaid Care A/S · Dec 2019
ExSpiron 2Xi
K192595 · Respiratory Motion · Dec 2019
Gas Module 3
K180788 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Oct 2018
ExSpiron 1Xi
K173181 · Respiratory Motion, Inc. · Mar 2018
ExSpiron 1Xi
K162131 · Respiratory Motion, Inc. · May 2017
EXSPIRON 1XI
K130170 · Respiratory Motion, Inc. · May 2013